Ascelia Pharma

Ascelia Pharma Cash Flow per Share

The Operating Cash Flow per Share of Ascelia Pharma (ACE.ST) as of Oct 18, 2026 is -0.57 SEK. In the previous year, Operating Cash Flow per Share was -0.65 SEK — a change of -12.90% (higher).

Cash Flow per Share

-0.57SEK

YoY

-12.90%

Last updated:

Operating Cash Flow per Share of Ascelia Pharma is 2025 -0.57 SEK. Operating Cash Flow per Share of Ascelia Pharma was 2024 -0.65 SEK. It decreases by -12.90% higher compared to the previous year.

The Ascelia Pharma Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
-0.93 SEK
Jan 1, 2019
-1.57 SEK
Jan 1, 2020
-2.99 SEK
Jan 1, 2021
-2.87 SEK
Jan 1, 2022
-3.72 SEK
Jan 1, 2023
-3.76 SEK
Jan 1, 2024
-0.65 SEK
Jan 1, 2025
-0.57 SEK
The Ascelia Pharma Cash Flow per Share history
YEARCash Flow per ShareYoY
-0.57SEK-12.90%
-0.65SEK-82.60%
-3.76SEK+1.00%
-3.72SEK+29.62%
-2.87SEK-3.86%
-2.99SEK+89.96%
-1.57SEK+69.33%
-0.93SEK+44.73%
-0.64SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ascelia Pharma Stock analysis

What does Ascelia Pharma do? Ascelia Pharma AB, based in Malmö, Sweden, operates in the Health Care sector, specializing in biotechnology. The company focuses on researching and developing pharmaceutical products for cancer treatment, including the imaging drug Mangoral and the chemotherapeutic agent Oncoral. Mangoral, having completed Phase II trials for liver MRI imaging in patients with kidney impairment, and Oncoral, in Phase I for gastric cancer treatment, form the core of its pipeline. Listed on March 13, 2019, Ascelia employs 24 full-time staff. Ascelia Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ascelia Pharma stock

Operating Cash Flow per Share of Ascelia Pharma is -0.57 SEK in 2025.

Operating Cash Flow per Share of Ascelia Pharma changed from -0.65 SEK to -0.57 SEK, representing a -12.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Ascelia Pharma since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Ascelia Pharma

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Ascelia Pharma